Exagen Inc. Achieves Key Milestone with 1,000,000th Patient Tested by AVISE® CTD
12. Dezember 2024 09:00 ET
|
Exagen Inc.
CARLSBAD, Calif., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Exagen Inc., a leading provider of autoimmune testing, today announced the completion of its 1,000,000th AVISE CTD test, marking a significant...
Exagen Inc. Completes Validation and Regulatory Submission for New Lupus and Rheumatoid Arthritis Biomarkers on the AVISE® CTD Platform
14. November 2024 16:30 ET
|
Exagen Inc.
CARLSBAD, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Exagen Inc., a leading provider of autoimmune testing, today announced the validation and regulatory submission for approval of new Systemic Lupus...
Incannex Completes Positive Pre-IND Meeting with US FDA on IHL-675A for Treatment of Rheumatoid Arthritis
26. Juli 2023 07:30 ET
|
Incannex Healthcare
MELBOURNE, Australia, July 26, 2023 (GLOBE NEWSWIRE) -- Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL), (‘Incannex’ or the ‘Company’) a clinical-stage pharmaceutical company developing unique...
ALLIANCE DEVELOPPEMENT CAPITAL (ADC SIIC) : Communiqué sur la mise à disposition du rapport financier semestriel au 30.06.2021
28. September 2021 13:30 ET
|
ALLIANCE DEVELOPPEMENT CAPITAL (ADC SIIC)
ADC SIIC Société Européenne au capital de 20 572 093,32 euros Siège social : Avenue de l'Astronomie, 9 - Saint-Josse-ten-Noode - 1210 Bruxelles (Belgique) 0526.937.652 ...
Sorrento Publishes Positive Initial Results of SOFUSA® Lymphatic Drug Delivery System in a Phase 1b Rheumatoid Arthritis Study Using Enbrel
23. August 2021 15:52 ET
|
Sorrento Therapeutics, Inc.
Rheumatoid Arthritis (RA) is one of many chronic autoimmune conditions affecting over 20 million people in the United States (NIH, 2017).Sofusa is a revolutionary technology which delivers biologic...
The Lancet Rheumatology Publishes Clinical Trial Data Demonstrating Promising Safety and Efficacy Profile for a Novel Bioelectronic Device in Patients with Drug Refractory Rheumatoid Arthritis
29. Juli 2020 09:00 ET
|
SetPoint Medical
VALENCIA, Calif., July 29, 2020 (GLOBE NEWSWIRE) -- SetPoint Medical, Inc. today announced that data from a first-in-human pilot trial that evaluated its proprietary Vagus Nerve Stimulation (VNS)...
eWellness Announces the Developing New Rheumatoid Arthritis Treatment Platform RA360
12. November 2019 09:00 ET
|
eWellness Healthcare Corp
Culver City, CA, Nov. 12, 2019 (GLOBE NEWSWIRE) -- eWellness Healthcare Corporation – (EWLL) – a provider of the state of the art PHZIO platform for the physical therapy (“PT”) and telehealth...
Deployment guide: Deploying a cloud on the NEC DX1000
23. April 2015 12:00 ET
|
Principled Technologies
DURHAM, NC--(Marketwired - April 23, 2015) - Principled Technologies developed a complete, free deployment guide that will show you how to easily prepare for, deploy, provision to, and scale a dense...